Rob Fuller comments on the combined Anthem and Cigna, and how the merger presents a very large problem in the commercial markets. He goes on to explain that “the companies will have some efficiency arguments if they’re challenged on that issue, particularly on things like analytics, underwriting and other background functions.” Experts said another regulatory hurdle that both deals likely would have to clear is how they would affect competition in public health insurance exchanges established under the health care reform law.
Posted on August 2, 2015
Recent Posts
Harry Nelson Interviewed on NPR: With telehealth abortion, doctors have to learn to trust and empower patientsHarry Nelson Interviewed on BBC News: US to require negative Covid tests for travelers from ChinaNelson Hardiman Ranked 2023 Tier 1 Healthcare Law Firm by U.S. News & World ReportHarry Nelson Interviewed on NewsNation Banfield: Fears over old sports medical forms and girls menstrual informationWith 3 New Additions, Nelson Hardiman Adds to the Leading Healthcare and Life Sciences Law Practice in Los Angeles